Bank of America’s Biomerica BMRA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-49
| Closed | -$124 | – | 5850 |
|
|
2025
Q4 | $124 | Buy |
49
+4
| +9% | +$10 | ﹤0.01% | 6789 |
|
|
2025
Q3 | $128 | Sell |
45
-2
| -4% | -$6 | ﹤0.01% | 7805 |
|
|
2025
Q2 | $148 | Buy |
47
+4
| +9% | +$14 | ﹤0.01% | 7897 |
|
|
2025
Q1 | $196 | Buy |
43
+2
| +5% | +$10 | ﹤0.01% | 7692 |
|
|
2024
Q4 | $98 | Hold |
41
| – | – | ﹤0.01% | 7739 |
|
|
2024
Q3 | $107 | Sell |
41
-144
| -78% | -$412 | ﹤0.01% | 7709 |
|
|
2024
Q2 | $650 | Buy |
185
+160
| +640% | +$815 | ﹤0.01% | 7303 |
|
|
2024
Q1 | $166 | Sell |
25
-3
| -11% | -$24 | ﹤0.01% | 7358 |
|
|
2023
Q4 | $274 | Buy |
28
+3
| +12% | +$23 | ﹤0.01% | 7335 |
|
|
2023
Q3 | $172 | Hold |
25
| – | – | ﹤0.01% | 7423 |
|
|
2023
Q2 | $272 | Hold |
25
| – | – | ﹤0.01% | 7366 |
|
|
2023
Q1 | $374 | Sell |
25
-4
| -14% | -$86 | ﹤0.01% | 7388 |
|
|
2022
Q4 | $764 | Sell |
29
-371
| -93% | -$10.7K | ﹤0.01% | 7383 |
|
|
2022
Q3 | $13K | Sell |
400
-104
| -21% | -$2.69K | ﹤0.01% | 7157 |
|
|
2022
Q2 | $12K | Sell |
504
-121
| -19% | -$3.46K | ﹤0.01% | 7336 |
|
|
2022
Q1 | $22K | Buy |
625
+121
| +24% | +$4.02K | ﹤0.01% | 7482 |
|
|
2021
Q4 | $16K | Sell |
504
-3
| -0.6% | -$116 | ﹤0.01% | 7577 |
|
|
2021
Q3 | $18K | Buy |
507
+3
| +0.6% | +$99 | ﹤0.01% | 7418 |
|
|
2021
Q2 | $16K | Sell |
504
-79
| -14% | -$2.68K | ﹤0.01% | 7192 |
|
|
2021
Q1 | $25K | Sell |
583
-21
| -3% | -$1.08K | ﹤0.01% | 6826 |
|
|
2020
Q4 | $24K | Sell |
604
-34
| -5% | -$1.7K | ﹤0.01% | 6545 |
|
|
2020
Q3 | $35K | Buy |
638
+50
| +9% | +$3.23K | ﹤0.01% | 6141 |
|
|
2020
Q2 | $34K | Buy |
588
+104
| +21% | +$5.83K | ﹤0.01% | 6121 |
|
|
2020
Q1 | $27K | Buy |
484
+5
| +1% | +$153 | ﹤0.01% | 6074 |
|
|
2019
Q4 | $12K | Hold |
479
| – | – | ﹤0.01% | 6616 |
|
|
2019
Q3 | $12K | Sell |
479
-66
| -12% | -$1.6K | ﹤0.01% | 6680 |
|
|
2019
Q2 | $11K | Buy |
545
+66
| +14% | +$1.27K | ﹤0.01% | 6700 |
|
|
2019
Q1 | $10K | Sell |
479
-9
| -2% | -$176 | ﹤0.01% | 6647 |
|
|
2018
Q4 | $7K | Sell |
488
-16
| -3% | -$360 | ﹤0.01% | 6695 |
|
|
2018
Q3 | $14K | Buy |
504
+25
| +5% | +$749 | ﹤0.01% | 6580 |
|
|
2018
Q2 | $15K | Hold |
479
| – | – | ﹤0.01% | 6577 |
|
|
2018
Q1 | $15K | Hold |
479
| – | – | ﹤0.01% | 6476 |
|
|
2017
Q4 | $14K | Hold |
479
| – | – | ﹤0.01% | 6517 |
|
|
2017
Q3 | $11K | Buy |
+479
| New | +$10.4K | ﹤0.01% | 6500 |
|
Other funds holding BMRA
VCM
VFT
NA
HCM
HI
MA
Bank of America's BMRA Position: Q1 2026 in Review
Bank of America sold out of Biomerica (BMRA) in Q1 2026, closing a stake of 49 shares — an estimated $124 sold.
Bank of America first reported a position in BMRA in Q3 2017 and held it in 34 quarters. The position peaked at $35K in Q3 2020. 11 funds tracked by Wall St. Rank hold BMRA as of Q1 2026.
- Bank of America reported no remaining Biomerica position as of Q1 2026 after selling out during the quarter.
- Bank of America sold 49 Biomerica shares in Q1 2026, an estimated $124.
- Bank of America first reported a position in Biomerica in Q3 2017 and held it in 34 quarters.
- Bank of America's Biomerica position peaked at $35K in Q3 2020.
- 11 funds tracked by Wall St. Rank held Biomerica as of Q1 2026.
Based on Bank of America's 13F filing for Q1 2026, filed 18 May 2026.